搜索临床试验以:Cutaneous T-Cell Lymphoma (CTCL)
总计12019个结果
-
Centre for Human Drug Research, NetherlandsLeiden University Medical Center; Micreos邀请报名
-
Rhizen Pharmaceuticals SA完全的
-
MedImmune LLC终止
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.完全的
-
Universitätsmedizin MannheimKlinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden; Klinikum Krefeld 和其他合作者完全的
-
European Organisation for Research and Treatment...终止早期蕈样肉芽肿皮肤 T 细胞淋巴瘤 (MF-CTCL)(IA-IB 期)法国
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.完全的
-
European Organisation for Research and Treatment...终止
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.完全的
-
Yale UniversityWallace Research Foundation终止
-
Angimmune LLCUniversity of Colorado, Denver; Washington University School of Medicine; Yale University; Dana-Farber... 和其他合作者未知
-
University of Alabama at BirminghamSeagen Inc.; Kyowa Kirin, Inc.招聘中
-
Anne Beaven, MDBoehringer Ingelheim; National Comprehensive Cancer Network撤销
-
Astex Pharmaceuticals, Inc.主动,不招人
-
Kyowa Kirin, Inc.主动,不招人
-
Kyowa Kirin, Inc.完全的
-
University of Pittsburgh完全的
-
Seagen Inc.招聘中淋巴瘤,大 B 细胞,弥漫性 | 淋巴瘤,非霍奇金 | 霍奇金病 | 淋巴瘤,T细胞,皮肤 | 淋巴瘤,T 细胞,外周 | 淋巴瘤、大细胞、间变性美国
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals完全的
-
Onxeo终止非霍奇金淋巴瘤 | 皮肤 T 细胞淋巴瘤 | 外周 T 细胞淋巴瘤美国, 德国, 以色列, 法国, 泰国
-
BioCryst Pharmaceuticals完全的
-
European Organisation for Research and Treatment...Hoffmann-La Roche终止